Chimerix Return on Investment 2011-2019 | CMRX

Current and historical return on investment (ROI) values for Chimerix (CMRX) over the last 10 years.
Chimerix ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2019-03-31 $-0.07B $0.16B -38.78%
2018-12-31 $-0.07B $0.18B -37.17%
2018-09-30 $-0.08B $0.19B -37.13%
2018-06-30 $-0.08B $0.19B -35.51%
2018-03-31 $-0.07B $0.21B -32.35%
2017-12-31 $-0.07B $0.22B -29.63%
2017-09-30 $-0.07B $0.24B -26.51%
2017-06-30 $-0.07B $0.25B -24.91%
2017-03-31 $-0.07B $0.26B -24.51%
2016-12-31 $-0.08B $0.28B -26.51%
2016-09-30 $-0.10B $0.29B -32.69%
2016-06-30 $-0.12B $0.30B -35.48%
2016-03-31 $-0.12B $0.31B -34.70%
2015-12-31 $-0.12B $0.34B -34.65%
2015-09-30 $-0.10B $0.37B -30.72%
2015-06-30 $-0.08B $0.40B -30.30%
2015-03-31 $-0.07B $0.26B -31.49%
2014-12-31 $-0.06B $0.28B -32.02%
2014-09-30 $-0.05B $0.18B -33.27%
2014-06-30 $-0.04B $0.19B -28.86%
2014-03-31 $-0.03B $0.09B -30.12%
2013-12-31 $-0.03B $0.10B -56.59%
2013-09-30 $-0.02B $0.11B -836.36%
2013-06-30 $-0.01B $0.12B 24.00%
2013-03-31 $-0.00B $-0.13B 3.67%
2012-12-31 $-0.00B $-0.09B 0.00%
2012-09-30 $0.00B $0.00B -8.79%
2012-06-30 $-0.01B $0.00B 39.56%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.172B $0.007B
Chimerix, Inc. engages in the discovery, development and commercialization of oral antiviral therapeutics for various medical needs. The Company is developing various product candidates for the treatment of dsDNA viruses, HIV, hepatitis C, influenza and smallpox which are under different phases of clinical development. It is also screening our proprietary Chimerix Chemical Library for compounds with activity against dengue virus, malaria and tuberculosis. Chimerix, Inc. is headquartered in Durham, North Carolina.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.615B 28.85
Medtronic (MDT) Ireland $132.640B 18.95
Stryker (SYK) United States $76.039B 27.14
Boston Scientific (BSX) United States $58.018B 27.81
Baxter (BAX) United States $41.696B 26.28
Zimmer Biomet Holdings (ZBH) United States $23.900B 15.35
Smith & Nephew SNATS (SNN) United Kingdom $18.990B 0.00
ResMed (RMD) United States $17.191B 32.85
Canopy Growth (CGC) Canada $13.701B 0.00
Bio-Rad Laboratories (BIO) United States $8.984B 47.63
Aurora Cannabis (ACB) Canada $7.565B 74.60
Hill-Rom Holdings (HRC) United States $6.984B 21.17
Insulet (PODD) United States $6.926B 504.61
Perrigo (PRGO) Ireland $6.188B 10.46
Haemonetics (HAE) United States $5.977B 48.79
GW Pharmaceuticals (GWPH) United Kingdom $5.182B 0.00
ICU Medical (ICUI) United States $5.138B 30.66
Hutchison China MediTech (HCM) China $3.897B 0.00
Neogen (NEOG) United States $3.107B 50.52
NuVasive (NUVA) United States $2.983B 24.36
Agios Pharmaceuticals (AGIO) United States $2.912B 0.00
National Vision Holdings (EYE) United States $2.413B 51.42
Quidel (QDEL) United States $2.341B 24.29
Aphria (APHA) $1.735B 0.00
Cardiovascular Systems (CSII) United States $1.450B 832.80
HEXO (HEXO) $1.317B 0.00
Phibro Animal Health (PAHC) United States $1.244B 18.64
AtriCure (ATRC) United States $1.171B 0.00
VAREX IMAGING (VREX) United States $1.134B 24.08
Lantheus Holdings (LNTH) United States $1.078B 28.62
OrganiGram Holdings (OGI) Canada $0.947B 0.00
NanoString Technologies (NSTG) United States $0.920B 0.00
PetIQ (PETQ) United States $0.860B 20.88
Quanterix (QTRX) United States $0.818B 0.00
MacroGenics (MGNX) United States $0.801B 0.00
Omeros (OMER) United States $0.762B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.733B 20.55
Cerus (CERS) United States $0.674B 0.00
TG Therapeutics (TGTX) United States $0.601B 0.00
OraSure Technologies (OSUR) United States $0.544B 25.03
LeMaitre Vascular (LMAT) United States $0.542B 26.25
Surmodics (SRDX) United States $0.533B 77.45
Meridian Bioscience (VIVO) United States $0.484B 14.79
Evolus (EOLS) United States $0.390B 0.00
Vapotherm (VAPO) United States $0.368B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.355B 0.00
Zynex (ZYXI) United States $0.339B 35.00
Utah Medical Products (UTMD) United States $0.316B 21.87
BioLife Solutions (BLFS) United States $0.286B 89.41
Cytosorbents (CTSO) United States $0.209B 0.00
Bovie Medical (APYX) United States $0.199B 0.00
Owens & Minor (OMI) United States $0.191B 4.04
Rockwell Medical (RMTI) United States $0.178B 0.00
Fonar (FONR) United States $0.145B 7.63
Female Health (VERU) United States $0.132B 0.00
BRAINSWAY LTD (BWAY) Israel $0.112B 0.00
Neurotrope (NTRP) United States $0.107B 0.00
Chembio Diagnostics (CEMI) United States $0.102B 0.00
InfuSystems Holdings (INFU) United States $0.088B 0.00
United-Guardian (UG) United States $0.086B 18.98
Surface Oncology (SURF) United States $0.081B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Trinity Biotech (TRIB) Ireland $0.040B 13.83
Senestech (SNES) United States $0.037B 0.00
GUARDION HEALTH (GHSI) United States $0.030B 0.00
Cellectar Biosciences (CLRB) United States $0.020B 0.00
Valeritas Holdings (VLRX) United States $0.015B 0.00
Myomo (MYO) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 3.86